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Background: Failures of post-exposure prophylaxis
following sexual exposure (PEPSE) to prevent serocon-
version have been reported and are often associated with
ongoing risk exposure. Understanding why men who have
sex with men (MSM) access PEPSE on some occasions
and not others may lead to more effective health
promotion and disease prevention strategies
Methods: A qualitative study design using semi-
structured interviews of 15 MSM within 6 months of
them initiating PEPSE treatment at an HIV outpatient
service in Brighton, UK.
Results: PEPSE seeking was motivated by a number of
factors: an episode that related to a particular sexual
partner and their behaviour; the characteristics of the
venue where the risk occurred; the respondent’s state of
mind and influences of alcohol and recreational drug use;
and their perceived beliefs on the effectiveness of PEPSE.
Help was sought in the light of a ‘‘one-off’’ or ‘‘unusual’’
event. Many respondents felt they were less likely to
behave in a risky manner following PEPSE.
Conclusion: If PEPSE is to be effective as a public health
measure, at risk individuals need to be empowered to
make improved risk calculations from an increased
perception that they could be exposed to HIV if they
continue their current behaviour patterns. The concern is
that PEPSE was sought by a low number of MSM
implying that a greater number are not using the service
based on failure to make accurate risk calculations or
recognise high-risk scenarios.
Post-exposure prophylaxis for sexual exposure
(PEPSE) is increasingly recommended for men
who have sex with men (MSM) following unpro-
tected anal intercourse.1 There has been a signifi-
cant increase in the awareness and uptake of PEPSE
since high profile health campaigns in the UK and a
high volume of discussion around PEP in the gay
press2 predating the publication of UK guidelines
for the use of PEPSE in 2006.2–6
PEP has been shown to be effective in occupa-
tional settings7 providing plausibility for its use
after sexual exposure. Good evidence for the
effectiveness of PEPSE has been shown in animal
models,8 and recently prospective data for the
prevention of mother-to-child transmission9 10 has
pointed to the feasibility of PEPSE for MSM.11–14
However, there have been numerous reports of
seroconversion following PEPSE,13–15 17–19 which has
been largely attributed to ongoing risk behaviour
and subsequent viral exposure.
There is widespread concern that the availability
of PEPSE encourages risk taking among MSM;13 20 21
however, this is difficult to prove. Some studies
suggest there is no change whereas others suggest
there is a decrease in risk-taking behaviour in the
short term.14 22–24 Long-term behaviour modifica-
tion does not appear to be sustained.13 25 26
The question remains as to why at-risk individuals
choose to take up PEPSE on one occasion over many
other possible exposures, what factors contribute to
this decision and whether behaviour patterns are
influenced by knowledge and experience of PEPSE.
The aim of this study is to investigate the factors
that led MSM to access PEPSE and to understand
their rationale for doing this. This will allow us to
develop focused health promotion and target those
who are not presenting for PEPSE in this relatively
new area of HIV medicine.
METHODS
Design
The study consisted of a qualitative design using
semi-structured interviews of 15 MSM within
6 months of them initiating PEPSE treatment at
an HIV outpatient service in Brighton, UK.
Interviews were tape recorded, transcribed and
analysed using framework analysis.
Participants
Participants were MSM attending a dedicated
PEPSE clinic who were currently receiving or had
received PEPSE in the last 6 months.
Seventy-five MSM attended the clinic between
January 2007 and January 2008 and were given a
patient information sheet and consent form by the
nurse consultant (EN). The recruitment period was
limited to 1 year due to time constraints. The aim
was to recruit sufficient numbers to achieve
theoretical saturation. Participants were only
approached in a nurse-led clinic following verbal
consent to being telephoned by the researcher the
following day. Altogether, 19 were approached and
15 subsequently agreed to be interviewed.
Interviews
Participants undertook a semi-structured interview
with a single interviewer (CS) in a designated
interview room separate from the HIV outpatient
services. The interviewer was not part of the clinic
staff and had no contact with the participants
outside of the research setting. A topic guide was
used to underpin the interviews, although ques-
tions were open-ended and non-directive allowing
participants to expand on their personal experi-
ences. Data were collected by audio-recording and
transcribed verbatim by an independent agency.
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Data analyses
Data were analysed by framework analysis, which seeks to take
the accounts and observations of the population being studied
and develop categories and themes from the data when and
where they arise.27 This consisted of repeated emersion and re-
emersion in the transcripts; identification of a thematic frame-
work (table 1); indexing and coding of the data; and mapping
and interpretation.28 CS carried out the principle analysis. Major
themes were checked and discussed with MF and CL. The later
transcripts failed to issue any novel themes or categories and it
was agreed that theoretical saturation had been reached.
Results
Of the fifteen MSM interviewed, seven participants were
currently taking PEP, four had finished treatment and were
awaiting 3 month follow-up and three were awaiting 6 month
testing (3 participants were currently taking, or had taken, a
previous course of PEPSE). The mean age was 33 years, with a
median age of 34 years (range 19–46). Twelve participants were
in full-time employment, two were unemployed and one was in
full-time education. Ten participants classed themselves as
white UK, four as white non-UK and one as black Caribbean. A
nationwide survey reported a similar demographic of MSM
with a median age of 34 years, although with higher numbers of
white British (79.4%) and fewer white non-UK (13.0%) and
1.4% black.16 These differences could be explained by local
population epidemiology.
Knowledge and understanding
All the participants were able to talk about their prior
knowledge of PEPSE before they presented to HIV/genito-
urinary medicine (GUM) services. That PEPSE was available and
it could potentially prevent HIV seroconversion was the
dominant theme; however, indepth knowledge of what PEPSE
consisted of was scant (box 1).
Sources of information largely consisted of magazines, posters
and leaflets, and the Terrence Higgins Trust campaigns. Again,
the details of any information seen was only basic and often
highlighted different levels of engagement in the health
promotion information when out socially.
All respondents were able to articulate a change in their
perceived level of understanding since they had presented for
treatment: the length of treatment that they would be taking
highly active antiretroviral therapy (HAART) and potential
treatment failure were new revelations to most of the
participants.
Perceptions of PEPSE effectiveness before and after contact
with HIV services were markedly varied. There was no obvious
pattern found, with many participants claiming to have ‘‘no
idea’’ before presenting. Others, who would not commit to a
figure, described a pragmatic belief along the lines of, ‘‘they say
it works, it’s better to be safe than sorry’’ (respondent 14) or ‘‘[I
didn’t know] figures, just there’s a way to stop the spread’’
(respondent 3). Many respondents recognised, after initiating
PEPSE, that success was dependent on other qualifiers; for
example, presenting in less than 72 hours, good adherence and if
the partner was known HIV positive or not.
Circumstances leading to PEPSE
The main circumstance leading to presentation for PEPSE was
unprotected anal intercourse (UAI); condom failure made up
only a small proportion (box 2). That a particular event was
worthy of PEPSE due to being a ‘‘rare’’ or a ‘‘one-off’’ event was
the dominant theme, as was the use of alcohol or drugs. This
was frequently attributed to behaviour that was particularly
‘‘unusual’’ or ‘‘out of character’’ representing a single episode
deviating from what was considered ‘‘normal’’ low-risk
behaviour. These findings echo previous work on the subject.2 18
Commonly, an unusual event was linked to an ‘‘unusual
partner’’ or a partner who had not been entirely honest with
them or even just receiving particular ‘‘feelings’’ from a person.
Alcohol and recreational drug use was a leading factor in
taking a risk worthy of PEPSE. Only a minority claimed not to
have drunk alcohol prior to sexual intercourse. Of the majority
who did, it was common to ascribe particular significance to
this in view of their ‘‘unusual’’ or ‘‘rare’’ behaviour that led to
PEPSE.
Most participants were able to articulate times when PEPSE
could have been applicable but was not sought. This linked
strongly with the themes already explored on the circumstances
leading to transmission and often a previous episode did not
fulfil the ‘‘special’’ status of being ‘‘unusual’’ or ‘‘one-off.’’
Indeed many recipients claimed they would always come for
PEPSE if they deemed it necessary. Some respondents said that
prior failed considerations to take PEPSE rested on a partner or
situation not confirming itself to be of high enough risk or not
having a confirmed HIV diagnosis in a partner. Not wanting to
‘‘waste’’ healthcare resources was identified by a minority of the
participants, although it was not clear to what extent this
influenced the decision not to come for PEPSE. Not knowing
about the 72 hour time to presentation rule was a further
reason, which highlighted a specific gap in knowledge, rather
than a difference in attitude, from some of the participants.
Concepts of risk and HIV
Type of partner was the major theme to arise (box 3). Participants
equated risk with a variety of aspects; for example, having other
sexually transmitted diseases, promiscuity, someone who was
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into ‘‘adventurous sex,’’ ‘‘guys who don’t do safe sex,’’ casual
partners and known HIV positive men. Universally, these were all
characteristics that were identified in other people and not
themselves. This theme linked strongly with a general theme of
‘‘othering’’ in which participants distanced themselves from
proceedings and implied the other party was responsible for the
risk, not themselves. This appropriation of responsibility being in
the realm of the ‘‘other,’’ as we have seen already, extended to the
use of alcohol and recreational drugs. These elements making an
‘‘unusual event’’ more likely or being the driving force for ‘‘heat of
the moment’’ encounters.
Most participants grouped the general concept of risk with
the risk of HIV and articulated this in the terminology of ‘‘thrill
seeking,’’ gambling or ‘‘regrettable’’ behaviour. Participants
frequently recognised themselves as belonging to a high-risk
demographic and responses were typically well-rehearsed and
informed as would be expected from such a targeted and heavily
researched population, although some purported to wanting to
rebel against this once in a while.
Risk was coupled to venue by many participants. Certain sex
venues, saunas or clubs were associated with risk. Others noted
that living in Brighton itself carried an increased risk of HIV.
Behaviour modification in the light of PEPSE
All participants stated that taking PEPSE had in some way
contributed to perceived modified behaviour (box 4). This was
seen in the dramatic reduction in UAI with casual partners since
taking PEP to a period of complete celibacy in some (although
the majority of participants had continued to have at least one
episode of UAI outside of the context of negotiated safety in the
last 6 months). Other participants used their experience of PEP
to modify certain behaviours that had led to taking it in the first
place. However, most considered their behaviours to be low risk
before they came for PEPSE.
In other cases PEPSE had changed their outlook on risk, but
they still recognised areas where risks could be allowed to occur.
That the existence and provision of PEPSE could have directly
influenced a particular risk was abhorrent to all the participants.
Most recounted prior themes of unusual events, alcohol and
drugs, or just misfortune as reasons for a particular risk. The
concept that PEPSE could be seen by some as a ‘‘safety net’’ or
analogous to the morning-after pill was well documented. The
participants frequently associated this thinking with other
MSM and not themselves, again reinforcing the theme of
‘‘othering’’ found earlier.
The benefit of hindsight weighed heavily on statements of
perceived behaviour modification and this followed firsthand
experience of length of treatment, potential side-effects and the
realisation they were taking HAART.
Participants who identified themselves as sometimes having
unprotected sex always qualified it with reference to the
partner’s status: either a ‘‘long-term relationship’’ or exclusively
‘‘trusted’’ or regular ‘‘casual partners’’. However, these arrange-
ments were rarely confirmed by mutual screening for HIV. In
other cases so-called ‘‘trusted partners’’ only later disclosed their
positive HIV status highlighting a disparity between subjective
and objective views of risk.
Box 1 Knowledge and understanding of post-exposure
prophylaxis for sexual exposure (PEPSE)
Knowledge prior to presentation for PEPSE
‘‘[I knew that] there was a treatment available. But yeah the
actual mechanics of it I wasn’t aware of.’’ (Respondent 1)
Finding out about PEPSE
‘‘I’d seen a poster in a gay venue… I don’t think there’s enough
info about PEP. Little leaflets on bars, you don’t pick them up
when you’re out drinking with friends. You know posters in
venues… I’ve seen them and you don’t pay much attention to
them.’’ (Respondent 10)
Realisation of what PEPSE entailed
‘‘I got home read through the leaflets and basically realised then
that it was a medication designed for people with HIV… It was a
bit of a slap round the face reading that.’’ (Respondent 1)
Understanding post-PEPSE
‘‘They were talking about like if you did it within the timescale,
like sort of 80% success rate, if not higher really.’’ (Respondent 8)
‘‘Well, it’s like really not very successful the PEP sometimes, but
sometimes very, very successful.’’ (Respondent 13)
Box 2 Circumstances leading to presentation of post-
exposure prophylaxis for sexual exposure (PEPSE)
Out of character behaviour
‘‘I had just separated recently, so it [UAI] was kind of a way of
me trying to react, I don’t know, trying to, just forget about it, just
have fun, you know do drugs and get drunk.’’ (Respondent 4)
Unusual event
‘‘It was certainly kind of a one-off I think… I was in a sauna,
where I’d gone after I’d been out drinking… it was something I
wouldn’t normally do because, like I said, I’d been in a
relationship for the previous six years.’’ (Respondent 9)
Partner characteristics
‘‘It was his attitude after the event, he was very cagey and went
very quiet… our encounter was an accident and he was sort of
very strange about it… he got a bit upset then disappeared very
quickly… it made alarm bells ring.’’ (Respondent 10)
‘‘He was into the heavier sort of sexual scene, more than I was…
through that there was obviously a greater danger… He asked
me to fist him after sex, which I was a bit reluctant to do because
my nails were sharp and it caused him to bleed… he then wanted
to have sex again at which point I refused until he cleaned himself
up, at this point I broached him on the subject of HIV status, he
told me he was positive.’’ (Respondent 15)
Alcohol and recreational drugs
‘‘Actually it was the case that night, I took drugs, I drank a lot, so
I wasn’t really aware of what I was doing. It just happened you
know, it was just more of a one off thing and that’s probably why
I was so worried about it.’’ (Respondent 4)
‘‘I certainly think [alcohol] was the primary reason for what
happened.’’ (Respondent 9)
‘‘I was really drunk and did something that was quite out of
character for myself.’’ (Respondent 11]
Why on this occasion and not others
‘‘All the circumstances around it which made me think well
maybe something’s trying to tell me something, that should go
and take some action.’’ [Respondent 8]
‘‘What was different? To be honest nothing apart from they didn’t
tell me they had HIV, so they might as well been positive and they
just didn’t tell me.’’ (Respondent 4)
Behaviour
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DISCUSSION
Although awareness of PEPSE was high, a detailed knowledge of
what it consisted of was lacking. Nonetheless, a substantial
change in the level of understanding post-treatment represents
the value of face-to-face health promotion in this setting. The
assumption is that better education of this population is
fundamental in reducing the number of sexual risks resulting
in PEPSE uptake; however, as of yet there is no evidence to
support this. Not wanting to waste healthcare resources
represented a trend amongst some participants that highlights
the problem of failing to present for PEPSE following risk. The
notion that PEPSE is a ‘‘one-off’’ has been raised by both MSM
and healthcare staff,2 as well as in previous studies,2 18 and the
extent of this in this study shows that better education is
needed to demonstrate that any risk meeting the guidelines is
worthy of PEPSE.
It appears to be the case that most of the participants could
identify occasions when a risk was worthy of PEPSE but they
did not seek help and of those that did an event was described as
‘‘unusual’’. This begs the question: how many other MSM are
involved in similar exposure events and yet do not have the
same triggers for presenting to clinic? Extra work needs to be
targeted at PEPSE understanding among MSM and improving
the accuracy of subjective risk calculations.
Although it is difficult to target subtle interactions and
subjective risk assessments that result in single episodes of risk,
the results found do suggest that more concentration on
lifestyle factors could play a part in reducing those needing
PEPSE. Risk was equated with alcohol, venue, partner char-
acteristics and life events, and it was these factors that were
perceived to have been modified by the participants after taking
PEPSE. Improvements in targeting men before they present for
PEPSE could be made, for example, by flagging high-risk
individuals presenting at GUM services and increasing their
ability to make risk assessments through risk-reduction coun-
selling and information packs.
Self-reporting of behaviour patterns, particularly the state-
ments that their ‘‘normal’’ behaviour was low risk, mimicked
data from other studies.2 18 It was interesting that the group
distanced themselves from what they considered to be high-risk
behaviour. As has been seen, a propensity for participants to
purport irresponsible behaviours to ‘‘others’’ demonstrates that
there is a problem with the subjective view of personal risk. It
seems that the key message that UAI is dangerous is embedded
within the population of PEPSE patients. However, UAI outside
of the context of ‘‘negotiated safety’’ combined with the
associated behaviours already mentioned represents a driving
reason for presentation. Furthermore, these presentations only
came as a result of a real suspicion, or genuine knowledge, that
the partner was HIV positive; otherwise the participants simply
did not present for PEPSE and continued to put themselves at
risk.
The fact that no participant agreed with the statement that
knowledge of PEPSE could increase risk behaviour was
encouraging, as was the overwhelming consensus that personal
experience of PEPSE had changed perceived behaviours for the
better. A long-term commitment to recognise that risks are
being taken and are not necessarily unusual or one-off is still in
doubt and thus far studies have only shown a reduction in risk
following PEPSE for 2 years or less.13 25 26 There are still good
grounds for supporting the theory that PEPSE does not increase
perceived risk behaviour in MSM and there is evidence that key
areas contributing to risk were identified and, subsequently,
perceived to be modified by the participants after taking PEPSE:
notably, alcohol consumption, partner selection, venues and
Box 3 Concepts of risk and contracting HIV
Rebelling against health promotion
‘‘’You must always use a condom,’ blah blah blah. You get this
kind of drummed into you that maybe some of them, some people
will just want to say ‘fuck you’ basically.’’ (Respondent 3)
Risky venues
‘‘Regularly going to the ‘Brighton cruising ground’ and not being
that careful… going to one of Brighton’s saunas and not being
careful. I don’t put myself at risk cruising around.’’ (Respondent
10)
Risky partners
‘‘Guys who don’t do safe sex, have multiple partners… it sounds
a bit xenophobic, like people from America are more likely to have
it than not… some guys just don’t like to wear condoms, some
guys try to push you into not wearing a condom.’’ (Respondent
10)
‘‘There was a weird rash on the face and part of the body so I
was very, very scared.’’ (Respondent 13)
Risky lifestyle
‘‘Being drunk or on drugs can make you just forget about how big
a risk you now take if you are doing unprotected sex.’’
(Respondent 2)
‘‘Taking drugs, alcohol or risking yourself, it’s too easy to lose
control of yourself, it can leave people to do whatever they want
with your body or… you know, it’s like you don’t pay attention.’’
(Respondent 13)
Box 4 Changes in behaviour and post-exposure
prophylaxis for sexual exposure (PEPSE)
Modification of sexual behaviour
‘‘I’ve slowed down a bit, I’m not going to the ‘bushes’ so much
and like maybe I’ll be seeing more people that I know better and
stuff like that, not too much casual sex now.’’ (Respondent 6)
Long term commitment to change
‘‘As time goes by it drifts back into the recesses of your mind
rather than the forefront, but I think I will probably be more
cautious.’’ (Respondent 15)
‘‘I’ll certainly learn from it and hopefully even if I’m blind drunk I’ll
kind of remember, you know, like to behave myself… [but] if it
was like five years later, or whatever, you know, we’re all kind of
human I guess.’’ (Respondent 9)
Knowledge of PEPSE being a catalyst for risky behaviours
‘‘No! [knowing about PEP] wouldn’t change anything for me. You
can’t use it like a morning after pill, they’ll stop giving it to you.’’
(Respondent 6)
‘‘[PEP] it’s not something that I can say ‘oh it’s ok I can do what I
want because I know I can just be like effing get it and it’ll be
alright.’’ (Respondent 12)
The benefit of hindsight
‘‘I don’t think it could make you more risky. I think anything but,
you know side-effects, appointments, remembering to take
meds… I’ve seen people in the waiting room I know and they
would obviously make like the complete two plus two decision in
their heads as soon as they see I’m here.’’ (Respondent 9)
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type of sex. It is important to note that there is a difference
between the participants’ perception of behaviour modification
and actual measurable changes in behaviour.
One of the most powerful implementations that could result
from this study is the provision of PEPSE ‘‘starter packs’’ that
allow MSM to initiate treatment themselves in the event of
sexual risk. This strategy has been trialed previously with some
success.14 By removing the perceived barriers regarding PEPSE,
and the concern of not wanting to waste the time and resources
of healthcare professionals, this could be a worthwhile strategy.
Furthermore, the process of obtaining these packs would
provide a point for health promotion and a focus to the
individual as to how to reflect differently on their own risk
experiences and ultimately avoid having to use them in the first
place.
Limitations
The use of a sample chosen for its convenience due to resource
and logistical restraints is rarely ideal and it must be recognised
that the population of MSM in Brighton is an already well
searched group. From analysing the data, two major improve-
ments would logically follow: the inclusion of a group of MSM
who had not taken PEPSE for sexual exposure and a long-term
follow-up of the study population. The former would certainly
improve areas where the experience of PEP had coloured the
opinions on risk and HIV and modified risk behaviour. The
latter would again give a better understanding into the effects of
PEPSE on future risk-reduction strategies with the ‘‘knee-jerk’’
element of the responses post-PEPSE counselling removed.
However, with these issues aside, this study does add valuable
understanding to MSM’s experience of PEPSE.
CONCLUSION
Individuals can never make entirely objective assessments of
risk probability; it is part and parcel of the human condition
that we are subjective beings and we make decisions based on
our social and sexual contexts. If PEPSE is to be effective as a
public health measure, at-risk individuals need to be empowered
to make improved subjective risk calculations. By increasing the
population of MSM’s perception as to the likelihood that they
could have been exposed to HIV through identification of
triggers that the men in this study identified, health promotion
can target additional interventions, information and even
starter packs to encourage MSM to reflect differently on their
own risk experiences.
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